Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 26,752 | 19,794 | 8,508 | 450 | -22,722 |
| Depreciation Amortization | 61,550 | 44,474 | 27,484 | 10,493 | 15,483 |
| Accounts receivable | -10,367 | -3,513 | -8,242 | -12,474 | 4,993 |
| Accounts payable and accrued liabilities | 3,769 | 244 | 1,935 | -108 | -5,903 |
| Other Working Capital | -25,299 | -15,079 | -13,238 | -23,917 | 18,181 |
| Other Operating Activity | 37,537 | 25,445 | 20,738 | 18,887 | 17,751 |
| Operating Cash Flow | $93,942 | $71,365 | $37,185 | $-6,669 | $27,783 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,546 | -4,065 | -1,662 | -836 | -6,438 |
| Purchase Sale Intangibles | -368,226 | -368,226 | -368,226 | -366,811 | N/A |
| Other Investing Activity | -368,226 | -368,226 | -368,226 | -366,811 | 0 |
| Investing Cash Flow | $-373,772 | $-372,291 | $-369,888 | $-367,647 | $-6,438 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 330,394 | 330,394 | 330,394 | 138,794 | N/A |
| Debt Repayment | -49,000 | -36,500 | -24,000 | -11,500 | N/A |
| Common Stock Issued | 7,335 | 7,152 | 6,437 | 197,184 | 2,863 |
| Other Financing Activity | -2,255 | -2,169 | -1,922 | -1,358 | -822 |
| Financing Cash Flow | $286,474 | $298,877 | $310,909 | $323,120 | $2,041 |
| Beginning Cash Position | 170,019 | 170,019 | 170,019 | 170,019 | 146,633 |
| End Cash Position | 176,663 | 167,970 | 148,225 | 118,823 | 170,019 |
| Net Cash Flow | $6,644 | $-2,049 | $-21,794 | $-51,196 | $23,386 |
| Free Cash Flow | |||||
| Operating Cash Flow | 93,942 | 71,365 | 37,185 | -6,669 | 27,783 |
| Capital Expenditure | -5,546 | -4,065 | -1,662 | -836 | -6,438 |
| Free Cash Flow | 88,396 | 67,300 | 35,523 | -7,505 | 21,345 |